Rezolute, Inc. (RZLT) stock
RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
$4.01+0.43 (+12.15%)
Close on Nov 17, 2026Market cap $388.34MP/E –Yield –
Rezolute enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Rezolute's enterprise value was $284.57M on Nov 11, 2026, against $732.68M a year earlier. Over the last 5 years it ranged from -$93.66M to $732.68M, with a median of $79.01M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $284.57M | +354.2% |
| 2025 | Dec 31, 2025 | $62.65M | -61.6% |
| 2024 | Dec 31, 2024 | $163.16M | – |
| 2023 | Dec 29, 2023 | -$62.18M | – |
| 2022 | Dec 30, 2022 | -$78.09M | -2048.7% |
| 2021 | Dec 31, 2021 | $4.01M | -93.7% |
| 2020 | Dec 31, 2020 | $63.94M | – |
| 2019 | Dec 31, 2019 | -$22.07M | – |
| 2018 | Dec 31, 2018 | -$11.57M | -126.6% |
| 2017 | Dec 29, 2017 | $43.53M | +27.3% |
| 2016 | Dec 30, 2016 | $34.19M | +3.1% |
| 2015 | Dec 31, 2015 | $33.18M | +79.6% |
| 2014 | Dec 31, 2014 | $18.47M | -85.5% |
| 2013 | Dec 31, 2013 | $127.20M | – |
See a number that looks wrong?